Featured News

SDRC News
Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs
Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs

A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...

A Python-Derived Molecule Called pTOS Could Point to New Weight-Loss Pathways 
A Python-Derived Molecule Called pTOS Could Point to New Weight-Loss Pathways 

SDRC Investigator Dr. Jonathan Long's latest research reveals how pTOS — a metabolite that surges dramatically in snake blood after a meal — may offer a novel approach to appetite regulation with implications for diabetes care.

SDRC members highlighted in the new "Walk with Me" video series
SDRC members highlighted in the new "Walk with Me" video series

If you’ve ever wondered what happens inside a research lab — and why it matters — this is a look behind the scenes. In Walk with Me, faculty including SDRC members C. Bertozzi, J. Wu and SK Kim talk about the questions guiding their work and the impact they hope to achieve.

More News

Yong Chong Yong Chong

Special Diabetes Section of Translational Behavioral Medicine Journal

How will low-, middle- and upper- income countries deal with the continued growth of diabetes and other chronic diseases? A group of papers published in a special section of Translational Behavioral Medicine journal describe innovative programs for improved diabetes prevention and management.

Read More